AdAlta (ASX:1AD) Other Stockholders Equity : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AdAlta Other Stockholders Equity?

AdAlta's Other Stockholders Equity for the quarter that ended in Dec. 2023 was A$0.00 Mil.

AdAlta's quarterly Other Stockholders Equity increased from Dec. 2022 (A$-0.00 Mil) to Jun. 2023 (A$0.00 Mil) and increased from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.00 Mil).

AdAlta's annual Other Stockholders Equity increased from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) but then declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil).

AdAlta Other Stockholders Equity Historical Data

The historical data trend for AdAlta's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Other Stockholders Equity Chart

AdAlta Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Stockholders Equity

Get a 7-Day Free Trial

AdAlta Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial										-	-	-	-	-

AdAlta Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

AdAlta Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of AdAlta's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AdAlta (ASX:1AD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083

Website

https://www.adalta.com.au

AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.

AdAlta (ASX:1AD) Headlines

No Headlines